Samuel N. Hazen - 10 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
10 Feb 2026
Net transactions value
-$10,705,212
Form type
4
Filing time
12 Feb 2026, 18:45:03 UTC
Previous filing
05 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAZEN SAMUEL N CEO, Director ONE PARK PLAZA, NASHVILLE /s/ Kevin A. Ball, Attorney-in-Fact 12 Feb 2026 0001216838

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +54,934 +176% $0.000000 86,165 10 Feb 2026 Direct F1
transaction HCA Common Stock Tax liability $10,705,212 -21,323 -25% $502.05 64,842 10 Feb 2026 Direct
holding HCA Common Stock 16,024 10 Feb 2026 By HD Trust
holding HCA Common Stock 16,731 10 Feb 2026 By 2023 GST Trust
holding HCA Common Stock 93,088 10 Feb 2026 By 2023 Trust
holding HCA Common Stock 178,289 10 Feb 2026 By 2024 GRAT
holding HCA Common Stock 200,000 10 Feb 2026 By 2025 GRAT
holding HCA Common Stock 813,320 10 Feb 2026 By LP
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.